Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial101

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial38

Views

Views
June 20252
July 202516
August 20252
September 20255
October 20253
November 20257
December 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil15
United Kingdom4
Canada1
Kenya1
Tunisia1
 

Top cities views

Views
Ashburn3
Campos dos Goytacazes2
Araputanga1
Belo Horizonte1
Belém1
Bragança Paulista1
Brooklyn1
Calgary1
Cleveland1
Dallas1